Dextropropoxyphene
Sold as Propoxypan
Every registration of this product has been cancelled.
[(2S,3R)-4-(Dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate
Drag to rotate. Structure from PubChem CID 10100.
Background
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| The Premier Pharmaceutical Co LtdCancelled | Propoxypan | 32 MG, 65 MG | B1245, B1246 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Propoxypan 32 MG CAPSULE DEXTROPROPOXYPHENE HYDROCHLORIDE A 32 MG | 32 MG | B1245 | Cancelled | Not determined | None |
| Propoxypan 65 MG CAPSULE DEXTROPROPOXYPHENE HYDROCHLORIDE A 65 MG | 65 MG | B1246 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S6: Dextropropoxyphene
- except preparations and mixtures for oral use containing 135 milligrams or less of dextropropoxyphene, calculated as the base, per dosage unit or with a concentration of not more than 2,5 percent in undivided preparations. (S5)
Consolidated Schedules 06 July 2026, lines 10156 to 10158
S5: Dextropropoxyphene
- preparations and mixtures for oral use containing not more than 135 milligrams of dextropropoxyphene, calculated as the base, per dosage unit or with a concentration of not more than 2,5 percent in undivided preparations. (S6)
Consolidated Schedules 06 July 2026, lines 9379 to 9381
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.